Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells

This publication has 13 references indexed in Scilit:

• Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors
  Bone Marrow Transplantation, 2001
• Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
  Journal of Clinical Oncology, 2000
• Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF
  Bone Marrow Transplantation, 1999
• Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells
  The Lancet, 1999
• Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy
  Bone Marrow Transplantation, 1999
• How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation?: Results of a computer simulation
  Experimental Hematology, 1999
• High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation
  Blood, 1998
• The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
  Journal of Hematotherapy, 1996
• Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
  The Lancet, 1996
• Expression of Cell Surface Markers during Differentiation of CD34+, CD38−/lo Fetal and Adult Bone Marrow Cells
  ImmunoMethods, 1994